|
105 Companies |
|
193 Products |
|
193 Products |
|
133 Mechanisms of Action |
|
26 Trials |
|
4426 News |
|
| «12...1011121314151617181920...8990» |
- New trial: REALITY III: Utility, Safety, and Effectiveness of the Bard LifeStent 5F Vascular Stent System (clinicaltrials.gov) - Mar 5, 2017
P=N/A, N=30, Recruiting, Sponsor: C. R. Bard
- | Trial primary completion date, Gene therapy: KAT301: EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease (clinicaltrials.gov) - Mar 3, 2017
P1, N=30, Active, not recruiting, Sponsor: Kuopio University Hospital
Trial primary completion date: Mar 2016 --> Mar 2019
- | Enrollment closed, Enrollment change, Trial primary completion date: STRATEGY-II: STRATEGY for Left Main Coronary Bifurcation Lesion II (clinicaltrials.gov) - Mar 3, 2017
P=N/A, N=200, Active, not recruiting, Sponsor: Samsung Medical Center
Trial primary completion date: Mar 2016 --> Mar 2019 Recruiting --> Active, not recruiting | N=700 --> 200 | Trial primary completion date: Jan 2017 --> Dec 2017
- | Enrollment closed: Vegan vs AHA Diet on Inflammation and Glucometabolic Profile in Patients With CAD (clinicaltrials.gov) - Mar 3, 2017
P4, N=100, Active, not recruiting, Sponsor: New York University School of Medicine
Recruiting --> Active, not recruiting | N=700 --> 200 | Trial primary completion date: Jan 2017 --> Dec 2017 Recruiting --> Active, not recruiting
- | Enrollment closed, Trial primary completion date: Aortic Valve and Root Measurements Under Real-Time 3-Dimensional Visualization During Angiography (clinicaltrials.gov) - Mar 3, 2017
P=N/A, N=23, Active, not recruiting, Sponsor: New York University School of Medicine
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2017 --> Jun 2016
- | ticagrelor / Generic mfg., aspirin / Generic mfg., clopidogrel / Generic mfg.
Enrollment change, Trial termination: Ticagrelor and Peripheral Arterial Disease (clinicaltrials.gov) - Mar 3, 2017
P4, N=26, Terminated, Sponsor: Arkansas Heart Hospital
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2017 --> Jun 2016 N=40 --> 26 | Recruiting --> Terminated; AZ discontinued study
- | atorvastatin / Generic mfg.
Trial completion, Enrollment change, Surgery: POST-OP Pilot: Pilot Study of Atorvastatin for Orthopedic Surgery Patients (clinicaltrials.gov) - Mar 1, 2017
P2, N=20, Completed, Sponsor: Hospital for Special Surgery, New York
N=40 --> 26 | Recruiting --> Terminated; AZ discontinued study Recruiting --> Completed | N=30 --> 20
- | New trial: Routine Or Selective Stress Testing After Revascularization: ROSSTAR Trial RCT Outline (clinicaltrials.gov) - Feb 28, 2017
P=N/A, N=1100, Not yet recruiting, Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
- | New trial: iCBT for Long-term Conditions in IAPT (clinicaltrials.gov) - Feb 28, 2017
P=N/A, N=105, Recruiting, Sponsor: Derek Richards
- | Enrollment change, Trial withdrawal: Beta-blocker Before Extubation (clinicaltrials.gov) - Feb 28, 2017
P=N/A, N=0, Withdrawn, Sponsor: Gregory A. Schmidt
Recruiting --> Completed | N=30 --> 20 N=50 --> 0 | Recruiting --> Withdrawn
- | Trial completion, Trial primary completion date: The TRUST Study - CardioVascular Imaging IMT (clinicaltrials.gov) - Feb 27, 2017
P4, N=184, Completed, Sponsor: University Hospital Inselspital, Berne
N=50 --> 0 | Recruiting --> Withdrawn Recruiting --> Completed | Trial primary completion date: Nov 2017 --> Dec 2016
- | Trial completion, Trial primary completion date: The TRUST Trial - CardioVascular Imaging ECHO (clinicaltrials.gov) - Feb 27, 2017
P4, N=185, Completed, Sponsor: University Hospital Inselspital, Berne
Recruiting --> Completed | Trial primary completion date: Nov 2017 --> Dec 2016 Recruiting --> Completed | Trial primary completion date: Nov 2017 --> Dec 2016
- | paclitaxel / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: The COPPER-B Trial (clinicaltrials.gov) - Feb 27, 2017
P=N/A, N=11, Completed, Sponsor: Horizons International Peripheral Group
Recruiting --> Completed | Trial primary completion date: Nov 2017 --> Dec 2016 Active, not recruiting --> Completed | N=60 --> 11 | Trial primary completion date: Jul 2017 --> Aug 2016
- | Enrollment change, Trial withdrawal: HeartHab, Can a Patient-tailored Application Support Coronary Artery Disease Patients During Rehabilitation? (clinicaltrials.gov) - Feb 27, 2017
P=N/A, N=0, Withdrawn, Sponsor: Hasselt University
Active, not recruiting --> Completed | N=60 --> 11 | Trial primary completion date: Jul 2017 --> Aug 2016 N=30 --> 0 | Not yet recruiting --> Withdrawn
- | Resolute ZES (zotarolimus-eluting stent) / Medtronic
Enrollment change, Trial termination, Trial primary completion date: LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery) (clinicaltrials.gov) - Feb 24, 2017
P4, N=302, Terminated, Sponsor: Seung-Jung Park
N=30 --> 0 | Not yet recruiting --> Withdrawn N=400 --> 302 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Feb 2017
- ||| Kanarb (fimasartan) - Boryung Group, R / Pharm
Enrollment closed, Enrollment change: FIMA-DEFERt: Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease (FIMA-DEFER) (clinicaltrials.gov) - Feb 24, 2017
P4, N=186, Active, not recruiting, Sponsor: Seung-Jung Park
N=400 --> 302 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Feb 2017 Recruiting --> Active, not recruiting | N=354 --> 186
- | Trial completion: Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression (clinicaltrials.gov) - Feb 24, 2017
P4, N=242, Completed, Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting --> Active, not recruiting | N=354 --> 186 Active, not recruiting --> Completed
- Enrollment change, Trial initiation date, Trial termination, Trial primary completion date: Evaluation of a Non-Invasive Electrocardiogram-Assisted Blood Pressure Monitor (clinicaltrials.gov) - Feb 24, 2017
P=N/A, N=3, Terminated, Sponsor: Health Parametrics Inc.
Active, not recruiting --> Completed N=20 --> 3 | Initiation date: Dec 2013 --> Apr 2015 | Active, not recruiting --> Terminated | Trial primary completion date: Sep 2015 --> May 2015; Technical issues & lack of funds
- | cenplacel (PDA-002) / Celularity
Trial completion: Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU (clinicaltrials.gov) - Feb 24, 2017
P1, N=15, Completed, Sponsor: Celgene
N=20 --> 3 | Initiation date: Dec 2013 --> Apr 2015 | Active, not recruiting --> Terminated | Trial primary completion date: Sep 2015 --> May 2015; Technical issues & lack of funds Active, not recruiting --> Completed
- | Trial suspension, Trial primary completion date: Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients (clinicaltrials.gov) - Feb 23, 2017
P1/2, N=14, Suspended, Sponsor: Assistance Publique - H
Active, not recruiting --> Completed Recruiting --> Suspended | Trial primary completion date: Jan 2017 --> Jan 2018
- | clopidogrel / Generic mfg.
Enrollment change, Trial initiation date, Trial termination, Trial primary completion date: STAMP-DES: Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation (clinicaltrials.gov) - Feb 23, 2017
P4, N=364, Terminated, Sponsor: CHEOL WHAN LEE, M.D., Ph.D
Recruiting --> Suspended | Trial primary completion date: Jan 2017 --> Jan 2018 N=1393 --> 364 | Initiation date: Jun 2015 --> Dec 2015 | Recruiting --> Terminated | Trial primary completion date: Dec 2018 --> Feb 2017; Slow enrollment
- || Enrollment closed: LOCOMOTIVE: "All Comers" Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes (clinicaltrials.gov) - Feb 23, 2017
P=N/A, N=75, Active, not recruiting, Sponsor: B. Braun Melsungen AG
N=1393 --> 364 | Initiation date: Jun 2015 --> Dec 2015 | Recruiting --> Terminated | Trial primary completion date: Dec 2018 --> Feb 2017; Slow enrollment Recruiting --> Active, not recruiting
- New trial: ORBID-OA: Feasibility of Orbital Atherectomy System in Calcified Bifurcation Lesion (clinicaltrials.gov) - Feb 23, 2017
P=N/A, N=30, Recruiting, Sponsor: Icahn School of Medicine at Mount Sinai
- | Trial completion: Improving Sleep for Healthy Hearts (clinicaltrials.gov) - Feb 23, 2017
P=N/A, N=34, Completed, Sponsor: Brigham and Women's Hospital
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Trial primary completion date: CPR Training: Video Self-Instruction Kit or Video-Only (clinicaltrials.gov) - Feb 23, 2017
P=N/A, N=5000, Active, not recruiting, Sponsor: University of Pennsylvania
Active, not recruiting --> Completed Trial primary completion date: Jun 2017 --> Jul 2015
- | Trial completion: Initial Human Validation of Simultaneous Dual-Tracer Cardiac PET Imaging (clinicaltrials.gov) - Feb 23, 2017
P, N=30, Completed, Sponsor: University of Michigan
Trial primary completion date: Jun 2017 --> Jul 2015 Active, not recruiting --> Completed
- || Enrollment change: ISAR2000: Coroflex ISAR 2000 Registry (clinicaltrials.gov) - Feb 23, 2017
P=N/A, N=2877, Active, not recruiting, Sponsor: B. Braun Melsungen AG
Active, not recruiting --> Completed N=2000 --> 2877
- | Trial completion, Trial primary completion date: DECODE: DNA Damage & Repair Proteins In Patients With Atherosclerotic Coronary Artery Disease (clinicaltrials.gov) - Feb 23, 2017
P=N/A, N=126, Completed, Sponsor: University of Surrey
N=2000 --> 2877 Recruiting --> Completed | Trial primary completion date: Apr 2016 --> Oct 2016
- | Trial completion: Determinants of Cardiac Risk Factor Modification in Latinos With Coronary Artery Disease (clinicaltrials.gov) - Feb 20, 2017
P=N/A, N=198, Completed, Sponsor: Weill Medical College of Cornell University
Recruiting --> Completed | Trial primary completion date: Apr 2016 --> Oct 2016 Recruiting --> Completed
- || Trial primary completion date: Q-CAMP: Non-invasive Computer-Aided Phenotyping of Vasculopathy (clinicaltrials.gov) - Feb 20, 2017
P=N/A, N=150, Recruiting, Sponsor: Elucid Bioimaging Inc.
Recruiting --> Completed Trial primary completion date: Dec 2016 --> Mar 2017
- Xience (everolimus-eluting stent) / Abbott
Enrollment change, Trial withdrawal, Cost of therapy: COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials (clinicaltrials.gov) - Feb 20, 2017
P4, N=0, Withdrawn, Sponsor: IHF GmbH - Institut f
Trial primary completion date: Dec 2016 --> Mar 2017 N=900 --> 0 | Not yet recruiting --> Withdrawn
- | New trial: Henry Ford Heart Score Randomized Trial: Rapid Discharge of Patients Evaluated for Possible Myocardial Infarction (clinicaltrials.gov) - Feb 19, 2017
P=N/A, N=105, Completed, Sponsor: Henry Ford Health System
- | clopidogrel / Generic mfg.
New P4 trial: OPTIMA-C: Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting Stents (clinicaltrials.gov) - Feb 16, 2017
P4, N=1368, Completed, Sponsor: Gangnam Severance Hospital
- ||||| New P2 trial: A Clinical Trial to Study the Efficacy and Safety of Stempeucel (clinicaltrials.gov) - Feb 16, 2017
P2, N=164, Not yet recruiting, Sponsor: Stempeutics Research Pvt Ltd
- | New trial: Diagnostic Accuracy to Detect Hemodynamically Significant Stenosis by Non-invasive SURECardio CT-FFR (clinicaltrials.gov) - Feb 16, 2017
P=N/A, N=59, Completed, Sponsor: Toshiba Medical Systems Corporation, Japan
- Trial completion: Exercise-training Before Coronary Artery Bypass Graft (CABG) (clinicaltrials.gov) - Feb 15, 2017
P=N/A, N=40, Completed, Sponsor: Norwegian University of Science and Technology
N=900 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Completed
- Phase classification, Trial primary completion date: CPR Training: Video Self-Instruction Kit or Video-Only (clinicaltrials.gov) - Feb 15, 2017
P=N/A, N=5000, Active, not recruiting, Sponsor: University of Pennsylvania
Recruiting --> Completed Phase classification: P2 --> P=N/A | Trial primary completion date: Dec 2016 --> Jun 2017
- Trial primary completion date: Patient Centered Home Exercise Program for Peripheral Artery Disease (clinicaltrials.gov) - Feb 15, 2017
P=N/A, N=200, Recruiting, Sponsor: Northwestern University
Phase classification: P2 --> P=N/A | Trial primary completion date: Dec 2016 --> Jun 2017 Trial primary completion date: Dec 2017 --> Jun 2018
- Phase classification, Trial termination: Coronary Bifurcation Lesions Treated With Biguard Stent System (clinicaltrials.gov) - Feb 14, 2017
P=N/A, N=400, Terminated, Sponsor: Nanjing First Hospital, Nanjing Medical University
Trial primary completion date: Dec 2017 --> Jun 2018 Phase classification: P4 --> P=N/A | Active, not recruiting --> Terminated; Funding issues
- ||| New trial: Sapphire II PRO US Clinical Study (clinicaltrials.gov) - Feb 14, 2017
P=N/A, N=60, Not yet recruiting, Sponsor: OrbusNeich
- New trial: Whole Milk Compared With Skimmed Milk and Effect on Lipids (clinicaltrials.gov) - Feb 14, 2017
P=N/A, N=18, Completed, Sponsor: University of Copenhagen
- Trial completion, Trial primary completion date: Heart Rate Variability as a Predictor of Ischemic Heart Disease (clinicaltrials.gov) - Feb 14, 2017
P=N/A, N=62, Completed, Sponsor: University of Iowa
Phase classification: P4 --> P=N/A | Active, not recruiting --> Terminated; Funding issues Recruiting --> Completed | Trial primary completion date: Nov 2016 --> Aug 2016
- New trial: System Delay and Clinical Outcome Among Chinese Patients With AMI Treated With Reperfusion Therapy (MOODY Study) (clinicaltrials.gov) - Feb 13, 2017
P=N/A, N=12000, Enrolling by invitation, Sponsor: The First Affiliated Hospital with Nanjing Medical University
- | Xience (everolimus-eluting stent) / Abbott
Phase classification: BIOSCIENCE: Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents (clinicaltrials.gov) - Feb 11, 2017
P=N/A, N=2119, Active, not recruiting, Sponsor: University Hospital Inselspital, Berne
Recruiting --> Completed | Trial primary completion date: Nov 2016 --> Aug 2016 Phase classification: P4 --> P=N/A
- Xience (everolimus-eluting stent) / Abbott
New trial: Efficacy of Angiolite Stent vs a Second-generation Drug-eluting Stent Xience for Percutaneous Coronary Intervention (clinicaltrials.gov) - Feb 10, 2017
P=N/A, N=220, Active, not recruiting, Sponsor: Cardiva2 S.L.
- New trial: MEASURE-cBP2: Non-invasive Validation of Non-invasive Central Blood Pressure Measurements Using Oscillometric Pulse Wave Analysis (clinicaltrials.gov) - Feb 10, 2017
P=N/A, N=100, Recruiting, Sponsor: Universit
- New trial: FOILP: Effects of Fish Oil on Platelet Function and Coagulation (clinicaltrials.gov) - Feb 9, 2017
P=N/A, N=10, Not yet recruiting, Sponsor: Region Skane
- Trial completion, Phase classification: Clinical Implications of Peripheral Plaque Morphology (clinicaltrials.gov) - Feb 8, 2017
P=N/A, N=143, Completed, Sponsor: The Cleveland Clinic
Phase classification: P4 --> P=N/A Active, not recruiting --> Completed | Phase classification: P4 --> PN/A
- Trial completion, Phase classification: Use of Different Diagnostic Coronary Catheters Over the Radial Access - the UDDC - Radial Trial (clinicaltrials.gov) - Feb 8, 2017
P=N/A, N=300, Completed, Sponsor: Charite University, Berlin, Germany
Active, not recruiting --> Completed | Phase classification: P4 --> PN/A Active, not recruiting --> Completed | Phase classification: P3 --> PN/A
- New trial: MEASURE-cBP1: Invasive Validation of Non-invasive Central Blood Pressure Measurements Using Oscillometric Pulse Wave Analysis (clinicaltrials.gov) - Feb 8, 2017
P=N/A, N=100, Active, not recruiting, Sponsor: Universit